Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach.

Retinitis pigmentosa (RP) is a group of genetic eye ... night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind until their ...

A person with Usher syndrome Type III starts with normal or near-normal hearing ... Another safety issue pertains to night blindness, usually the first manifestation of retinitis pigmentosa. A child ...

More than half of people with mitochondrial disease can ... that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases. Using advanced proteomics ...

Scientists could those save the sight of people suffering from age-related macular degeneration and retinitis by taking nerve cells from the leg and injecting them into the damaged area of the eye.

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited ... Approximately 100,000 people in the US and an estimated 2 million people worldwide suffer ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa ... 100,000 people in the US and an ...

Fellow-KI researchers Anders Kvanta and Fredrik Lanner have been awarded a grant of SEK 10 million from the Promobilia foundation to develop a ...